| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥260.6B | ¥266.1B | -2.1% |
| Operating Income | ¥15.0B | ¥24.6B | -39.0% |
| Ordinary Income | ¥21.9B | ¥28.5B | -23.1% |
| Net Income | ¥11.6B | ¥20.3B | -43.1% |
| ROE | 1.7% | 3.0% | - |
FY2025 Q3 cumulative results for Icom (6820) showed revenue of 26.06 billion yen (YoY -2.1%), operating income of 1.50 billion yen (YoY -39.0%), ordinary income of 2.19 billion yen (YoY -23.1%), and net income of 1.16 billion yen (YoY -43.1%). The company faced significant profit erosion despite relatively stable revenues, with operating margin declining to 5.8% from 9.2% in the prior year period. Non-operating income of 7.05 billion yen, including foreign exchange gains of 3.21 billion yen, partially mitigated the operating profit decline. Special losses of 4.00 billion yen related to litigation expenses further compressed net income. The balance sheet remains solid with total assets of 76.88 billion yen and equity of 69.28 billion yen, maintaining an equity ratio of 90.1%. Cash and deposits stand at 26.15 billion yen, providing substantial liquidity cushion.
Revenue of 26.06 billion yen decreased 2.1% YoY, reflecting a marginal contraction in total sales across most geographic segments. By segment, Japan generated sales of 14.45 billion yen (nearly flat YoY from 14.47 billion yen), North America recorded 8.44 billion yen (down 6.4% from 9.02 billion yen), Europe contributed 2.01 billion yen (up 3.5% from 1.95 billion yen), and Asia-Oceania delivered 1.15 billion yen (down 2.7% from 1.18 billion yen). The revenue decline was primarily driven by North America market contraction, partially offset by modest European growth. On the profit side, gross profit margin remained healthy at 43.4%, indicating stable product pricing and manufacturing efficiency. However, selling, general and administrative expenses increased to 9.82 billion yen, with personnel costs of 2.69 billion yen representing a significant burden. The SG&A expense ratio rose, compressing operating margin from 9.2% to 5.8%. Operating income fell sharply to 1.50 billion yen from 2.46 billion yen, a 39.0% decline. Non-operating income contributed positively with interest income of 0.21 billion yen, dividend income of 0.13 billion yen, and foreign exchange gains of 3.21 billion yen, adding 6.95 billion yen net non-operating contribution. This brought ordinary income to 2.19 billion yen, down 23.1% YoY but showing smaller decline than operating income due to favorable non-operating factors. A special loss of 4.00 billion yen related to litigation expenses represented a non-recurring factor that significantly impacted net income. After tax effects, net income attributable to owners declined 43.1% to 1.16 billion yen. The gap between ordinary income of 2.19 billion yen and net income of 1.16 billion yen (approximately 47% reduction) stems from the special litigation-related loss, which is a one-time factor not expected to recur. This represents a revenue flat, profit down pattern driven by operating expense inflation, geographic mix shift, and extraordinary litigation costs.
Japan remains the core business with sales of 21.20 billion yen (including internal transfers of 6.75 billion yen) and operating income of 1.29 billion yen, representing an operating margin of 6.1%. Japan's external customer sales of 14.45 billion yen account for 55.5% of consolidated revenue, confirming its position as the largest market. Operating income decreased from 1.91 billion yen in the prior year to 1.29 billion yen, a decline of 32.5%. North America reported sales of 8.49 billion yen and an operating loss of 0.17 billion yen, deteriorating sharply from an operating profit of 0.14 billion yen in the prior year. This represents a swing to negative margin territory, indicating significant operational challenges in the region. Europe generated sales of 2.02 billion yen with operating income of 0.14 billion yen, yielding an operating margin of 7.0%, broadly stable compared to prior year margin of 7.1%. Asia-Oceania recorded sales of 1.29 billion yen and operating income of 0.06 billion yen, representing a 4.7% margin, down from 6.9% in the prior year. Material margin differences exist between segments, with Europe maintaining the highest margin at 7.0% followed by Japan at 6.1%, while North America incurred losses and Asia-Oceania margins compressed. The North America segment's shift to losses is the most concerning development, warranting close attention to cost structure and demand conditions in that market.
[Profitability] ROE of 1.7% represents a significant deterioration from higher historical levels, with net profit margin of 4.4% reflecting the combined impact of operating margin compression to 5.8% and special losses. Operating margin of 5.8% declined 3.4 percentage points from 9.2% in the prior year, driven by SG&A expense burden increasing relative to sales. Gross profit margin of 43.4% indicates maintained product-level profitability. ROIC of 2.2% falls below the company's cost of capital, signaling suboptimal capital efficiency. [Cash Quality] Cash and cash equivalents of 26.15 billion yen provide substantial liquidity, representing 34.0% of total assets. The cash position covers short-term liabilities 5.5 times, indicating very strong short-term debt servicing capacity. However, working capital efficiency has deteriorated markedly, with inventory of 8.17 billion yen and accounts receivable of 5.48 billion yen indicating extended operating cycles. [Investment Efficiency] Total asset turnover of 0.34 times reflects sluggish asset utilization, below the manufacturing sector median of 0.58 times. Inventory turnover days of 114.6 days and receivables turnover days of 76.9 days indicate working capital tied up in operations, contributing to the low asset turnover. [Financial Health] Equity ratio of 90.1% is exceptionally strong, well above the industry median of 63.8%. Current ratio of 1,037.3% provides substantial liquidity cushion. Debt-to-equity ratio of 0.11 times indicates minimal leverage, with total liabilities representing only 9.9% of total assets. The balance sheet reflects financial conservatism with negligible solvency risk.
Cash and deposits increased 2.28 billion yen YoY to 26.15 billion yen, reflecting continued cash accumulation despite profit decline. The increase in cash position indicates operating activities generated positive cash flows, though likely at reduced levels given the 43.1% decline in net income. Working capital movements show mixed signals, with inventory increasing 0.63 billion yen YoY to 8.17 billion yen and accounts receivable rising 0.57 billion yen to 5.48 billion yen, suggesting working capital absorption rather than release. Accounts payable increased 1.21 billion yen to 4.50 billion yen, representing a 36.8% increase that partially offset working capital usage through extended supplier payment terms. The company's substantial equity base of 69.28 billion yen increased 2.85% YoY, supported by retained earnings accumulation. Short-term debt coverage stands at 5.5 times based on cash relative to current liabilities of 4.73 billion yen, indicating ample liquidity for near-term obligations. The balance sheet structure with 63.8% of assets in current form and minimal interest-bearing debt suggests low refinancing risk. However, the deterioration in inventory and receivables turnover implies operating cash generation quality has weakened, as more capital is tied up in working capital relative to sales levels.
Ordinary income of 2.19 billion yen versus operating income of 1.50 billion yen shows non-operating net contribution of approximately 0.69 billion yen, comprising primarily foreign exchange gains of 3.21 billion yen, interest income of 0.21 billion yen, and dividend income of 0.13 billion yen, partially offset by non-operating expenses. Non-operating income represents 27.0% of revenue, an elevated proportion indicating significant earnings contribution from non-core activities rather than core operations. The foreign exchange gains of 3.21 billion yen are subject to currency volatility and reduce earnings predictability, as this component can reverse in future periods depending on exchange rate movements. The gap between ordinary income of 2.19 billion yen and net income of 1.16 billion yen of approximately 1.03 billion yen stems from special losses of 4.00 billion yen related to litigation expenses, representing a non-recurring factor that distorts year-over-year comparability. Excluding this one-time charge would imply normalized net income closer to operating performance levels. The deterioration in working capital metrics, with inventory days increasing to 114.6 and receivables days to 76.9, suggests accruals quality concerns as revenue recognition may be outpacing cash realization. Without quarterly cash flow statement data, the relationship between net income and operating cash flow cannot be directly verified, but the working capital buildup implies operating cash flow likely lagged net income substantially. Earnings quality assessment indicates heavy reliance on non-operating items and one-time charges affecting reported results, with core operational earning power weakened by margin compression and working capital inefficiency.
Full-year guidance calls for revenue of 36.00 billion yen, operating income of 2.55 billion yen, ordinary income of 3.08 billion yen, and net income of 1.98 billion yen. Through Q3 cumulative, the company achieved 72.4% of revenue guidance, 58.8% of operating income guidance, 71.2% of ordinary income guidance, and 58.3% of net income guidance. Standard progress at Q3 would be 75%, indicating the company is tracking below normal pace across all profit metrics, particularly operating and net income which show significant shortfalls of 16.2 and 16.7 percentage points respectively. Revenue progress of 72.4% is relatively close to the 75% benchmark, suggesting the primary challenge lies in profitability rather than top-line generation. To achieve full-year guidance, Q4 would require revenue of 9.94 billion yen (38.1% of annual target in a single quarter), operating income of 1.05 billion yen (41.2% of annual target), and net income of 0.82 billion yen (41.7% of annual target). This implies a strong Q4 recovery in profitability, requiring either significant cost reduction, favorable product mix shift, or non-recurrence of Q3 special losses. Given that Q3 cumulative operating margin was 5.8%, achieving full-year operating margin of 7.1% requires Q4 margin improvement to approximately 10.6%, representing a substantial sequential uplift from current run-rate. The company has revised full-year guidance downward with revenue declining 3.9%, operating income declining 31.5%, and ordinary income declining 21.1% compared to prior year. The revised guidance already reflects expectations of challenging conditions, but Q3 progress rates below 75% for profit metrics suggest execution risk remains for achieving even these reduced targets.
The company has declared a Q2 interim dividend of 25.0 yen per share and disclosed a year-end dividend of 58.0 yen per share, totaling 83.0 yen per share on an annualized basis. However, full-year guidance indicates an expected dividend of 35.0 yen per share, creating a discrepancy between period disclosures and company forecast that requires clarification. Using the disclosed interim and year-end figures totaling 83.0 yen per share against net income per share of 80.49 yen yields a payout ratio of 103.1%, exceeding 100% and indicating dividends surpass current period earnings. Against full-year guided net income of 1.98 billion yen (137.96 yen per share based on guidance EPS), the forecasted 35.0 yen dividend would represent a payout ratio of 25.4%, which is more sustainable. The discrepancy requires monitoring for actual dividend policy execution. Based on 14.35 million outstanding shares and the disclosed cumulative dividend of 83.0 yen per share, total dividend outlay would be 1.19 billion yen, exceeding the Q3 cumulative net income of 1.16 billion yen by 2.6%, confirming the payout ratio exceeds 100% if these dividends are fully executed. The company maintains substantial cash reserves of 26.15 billion yen, providing capacity to sustain dividends temporarily above earnings, but continued payout ratios exceeding 100% would gradually erode capital and limit reinvestment capacity. No share buyback activity is disclosed in the available data. Total shareholder return would be equivalent to the dividend yield absent buybacks.
Operating profit margin compression risk driven by persistent SG&A expense inflation. SG&A expenses of 9.82 billion yen represented 37.7% of revenue in Q3 cumulative, up from 35.0% in the prior year. Personnel costs of 2.69 billion yen comprise 27.4% of SG&A, and continued wage pressure or headcount expansion without corresponding revenue growth would further compress margins. North America segment operating loss of 0.17 billion yen represents a deterioration of 0.31 billion yen versus prior year profit of 0.14 billion yen. Geographic concentration risk in North America, representing 32.4% of revenue, creates vulnerability if demand conditions or competitive dynamics in this market continue to weaken. Working capital efficiency deterioration risk evidenced by inventory turnover extending to 114.6 days and receivables turnover to 76.9 days. Inventory of 8.17 billion yen increased 8.4% YoY while revenue declined 2.1%, indicating inventory buildup relative to sales that risks obsolescence or markdowns. Accounts receivable of 5.48 billion yen growing faster than revenue suggests collection challenges or extended payment terms that constrain cash generation. Combined, operating working capital cycle extended to 135.4 days from more efficient levels, tying up approximately 10.20 billion yen in working capital (39.1% of revenue), limiting financial flexibility and return on invested capital.
[Industry Position] (Reference - Proprietary Analysis) Profitability: ROE 1.7% substantially trails industry median of 5.2% (Q3 2025, n=100 manufacturing companies), placing the company in the bottom quartile. Operating margin of 5.8% falls below industry median of 8.7%, indicating weaker operational efficiency. Net profit margin of 4.4% versus industry median of 6.4% reflects both operating margin weakness and impact of special losses. Efficiency: Total asset turnover of 0.34 times significantly lags industry median of 0.58 times, driven by working capital inefficiency. Inventory turnover days of 114.6 exceed industry median of 108.8 days, though within interquartile range. Receivables turnover days of 76.9 fall within industry median of 82.9 days. Operating working capital cycle of 135.4 days exceeds industry median of 108.1 days, indicating slower cash conversion. Financial Health: Equity ratio of 90.1% substantially exceeds industry median of 63.8%, reflecting conservative capital structure. Current ratio of 10.4 times well above industry median of 2.8 times indicates excess liquidity. Financial leverage of 1.11 times versus industry median of 1.53 times shows minimal debt usage. Growth: Revenue decline of 2.1% YoY compares unfavorably to industry median revenue growth of 2.8%, placing the company below median performance. EPS decline of 43.1% substantially trails industry median EPS growth of 6.0%. Returns: ROA of 1.5% falls below industry median of 3.3%. ROIC of 2.2% trails industry median of 6.0%, indicating capital is deployed at returns below industry standards. Overall assessment indicates the company maintains exceptionally strong financial health with conservative leverage and high liquidity, but significantly underperforms industry benchmarks on profitability, efficiency, and growth metrics. The company's working capital management and operating margin require improvement to achieve industry-median performance levels. (Industry: Manufacturing, N=100 companies, Comparison: FY2025 Q3 period, Source: Proprietary analysis)
Operating margin compression from 9.2% to 5.8% driven by SG&A expense inflation relative to flat revenues represents the primary earnings headwind, with North America segment swinging to operating losses indicating geographic-specific challenges requiring operational restructuring. Working capital efficiency deterioration is a structural concern, with inventory and receivables growing faster than sales and extending the operating cycle to 135.4 days, tying up capital equivalent to 39.1% of revenue and constraining both return on invested capital and free cash flow generation. Dividend sustainability warrants monitoring given the disclosed payout ratio exceeding 100% of Q3 cumulative earnings, though substantial cash reserves of 26.15 billion yen provide temporary capacity to maintain distributions; clarification is needed regarding the discrepancy between period-disclosed dividends totaling 83.0 yen per share and full-year guidance of 35.0 yen per share.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.